Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor.

Identifieur interne : 006472 ( Main/Exploration ); précédent : 006471; suivant : 006473

Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor.

Auteurs : S. Matsuyama [Japon] ; F. Taguchi

Source :

RBID : pubmed:10891410

Descripteurs français

English descriptors

Abstract

Mouse hepatitis virus (MHV) JHMV and its soluble receptor-resistant (srr) mutants, srr7, srr11, and srr18, grew and induced syncytia equally well in BHK-R1 cells expressing the MHVR1 receptor derived from MHV-susceptible BALB/c mice. In contrast, srr growth and syncytia formations were drastically reduced relative to wild-type (wt) virus in BHK-R2 cells expressing the MHVR2 receptor from MHV-resistant SJL mice. Infections by these srr mutants in BHK-R2 cells were 0.7 to 1.5 log10 less efficient than those of wt virus. BHK cells expressing both MHVR1 and MHVR2 supported srr replication to the same extent as did BHK-R1 cells, suggesting that inefficient infection by srr mutants in BHK-R2 cells resulted from the absence of the effective receptor MHVR1. Virus-receptor binding tests failed to demonstrate a difference between the abilities of wt and srr18 to bind MHVR2. The binding of srr7 and srr11 to both MHVR1 and MHVR2 was revealed lower by two- to fourfold relative to the wt binding. The fusion activity of srr S proteins as examined by the expression with recombinant vaccinia virus was apparently lower than that of the wt S protein in BHK-R2 cells, while there was not such a remarkable difference in BHK-R1 cells. This suggests that the most likely reason for inefficient infection by mutants in BHK-R2 is impaired virus entry into cells. These observations suggest that inefficient infections in BHK-R2 cells by srr mutants occur in the absence of a functional receptor MHVR1, which plays an important role in srr entry into cells.

DOI: 10.1006/viro.2000.0409
PubMed: 10891410


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor.</title>
<author>
<name sortKey="Matsuyama, S" sort="Matsuyama, S" uniqKey="Matsuyama S" first="S" last="Matsuyama">S. Matsuyama</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Institute of Neuroscience, NCNP 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8502, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>National Institute of Neuroscience, NCNP 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8502</wicri:regionArea>
<wicri:noRegion>187-8502</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Taguchi, F" sort="Taguchi, F" uniqKey="Taguchi F" first="F" last="Taguchi">F. Taguchi</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10891410</idno>
<idno type="pmid">10891410</idno>
<idno type="doi">10.1006/viro.2000.0409</idno>
<idno type="wicri:Area/PubMed/Corpus">003475</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003475</idno>
<idno type="wicri:Area/PubMed/Curation">003475</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003475</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003363</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003363</idno>
<idno type="wicri:Area/Ncbi/Merge">000008</idno>
<idno type="wicri:Area/Ncbi/Curation">000008</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000008</idno>
<idno type="wicri:doubleKey">0042-6822:2000:Matsuyama S:impaired:entry:of</idno>
<idno type="wicri:Area/Main/Merge">006987</idno>
<idno type="wicri:Area/Main/Curation">006472</idno>
<idno type="wicri:Area/Main/Exploration">006472</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor.</title>
<author>
<name sortKey="Matsuyama, S" sort="Matsuyama, S" uniqKey="Matsuyama S" first="S" last="Matsuyama">S. Matsuyama</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Institute of Neuroscience, NCNP 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8502, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>National Institute of Neuroscience, NCNP 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8502</wicri:regionArea>
<wicri:noRegion>187-8502</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Taguchi, F" sort="Taguchi, F" uniqKey="Taguchi F" first="F" last="Taguchi">F. Taguchi</name>
</author>
</analytic>
<series>
<title level="j">Virology</title>
<idno type="ISSN">0042-6822</idno>
<imprint>
<date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antigens, CD</term>
<term>Carcinoembryonic Antigen</term>
<term>Cell Adhesion Molecules</term>
<term>Cell Fusion</term>
<term>Cell Line</term>
<term>Cell Membrane (metabolism)</term>
<term>Cricetinae</term>
<term>Giant Cells (cytology)</term>
<term>Giant Cells (metabolism)</term>
<term>Giant Cells (virology)</term>
<term>Glycoproteins (genetics)</term>
<term>Glycoproteins (metabolism)</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Murine hepatitis virus (genetics)</term>
<term>Murine hepatitis virus (growth & development)</term>
<term>Murine hepatitis virus (metabolism)</term>
<term>Murine hepatitis virus (physiology)</term>
<term>Mutation (genetics)</term>
<term>Receptors, Virus (genetics)</term>
<term>Receptors, Virus (metabolism)</term>
<term>Solubility</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Transfection</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Envelope Proteins (metabolism)</term>
<term>Viral Plaque Assay</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Antigène carcinoembryonnaire</term>
<term>Antigènes CD</term>
<term>Cellules géantes (cytologie)</term>
<term>Cellules géantes (métabolisme)</term>
<term>Cellules géantes (virologie)</term>
<term>Cricetinae</term>
<term>Fusion cellulaire</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines (génétique)</term>
<term>Glycoprotéines (métabolisme)</term>
<term>Glycoprotéines membranaires (génétique)</term>
<term>Glycoprotéines membranaires (métabolisme)</term>
<term>Lignée cellulaire</term>
<term>Membrane cellulaire (métabolisme)</term>
<term>Molécules d'adhérence cellulaire</term>
<term>Mutation (génétique)</term>
<term>Méthode des plages virales</term>
<term>Protéines de l'enveloppe virale (génétique)</term>
<term>Protéines de l'enveloppe virale (métabolisme)</term>
<term>Récepteurs viraux (génétique)</term>
<term>Récepteurs viraux (métabolisme)</term>
<term>Solubilité</term>
<term>Transfection</term>
<term>Virus de l'hépatite murine (croissance et développement)</term>
<term>Virus de l'hépatite murine (génétique)</term>
<term>Virus de l'hépatite murine (métabolisme)</term>
<term>Virus de l'hépatite murine (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Glycoproteins</term>
<term>Membrane Glycoproteins</term>
<term>Receptors, Virus</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Glycoproteins</term>
<term>Membrane Glycoproteins</term>
<term>Receptors, Virus</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Antigens, CD</term>
<term>Carcinoembryonic Antigen</term>
<term>Cell Adhesion Molecules</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr">
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Cellules géantes</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Giant Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Murine hepatitis virus</term>
<term>Mutation</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en">
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Glycoprotéines</term>
<term>Glycoprotéines membranaires</term>
<term>Mutation</term>
<term>Protéines de l'enveloppe virale</term>
<term>Récepteurs viraux</term>
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cell Membrane</term>
<term>Giant Cells</term>
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cellules géantes</term>
<term>Glycoprotéines</term>
<term>Glycoprotéines membranaires</term>
<term>Membrane cellulaire</term>
<term>Protéines de l'enveloppe virale</term>
<term>Récepteurs viraux</term>
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Cellules géantes</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Giant Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Fusion</term>
<term>Cell Line</term>
<term>Cricetinae</term>
<term>Solubility</term>
<term>Transfection</term>
<term>Viral Plaque Assay</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Antigène carcinoembryonnaire</term>
<term>Antigènes CD</term>
<term>Cricetinae</term>
<term>Fusion cellulaire</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Lignée cellulaire</term>
<term>Molécules d'adhérence cellulaire</term>
<term>Méthode des plages virales</term>
<term>Solubilité</term>
<term>Transfection</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Mouse hepatitis virus (MHV) JHMV and its soluble receptor-resistant (srr) mutants, srr7, srr11, and srr18, grew and induced syncytia equally well in BHK-R1 cells expressing the MHVR1 receptor derived from MHV-susceptible BALB/c mice. In contrast, srr growth and syncytia formations were drastically reduced relative to wild-type (wt) virus in BHK-R2 cells expressing the MHVR2 receptor from MHV-resistant SJL mice. Infections by these srr mutants in BHK-R2 cells were 0.7 to 1.5 log10 less efficient than those of wt virus. BHK cells expressing both MHVR1 and MHVR2 supported srr replication to the same extent as did BHK-R1 cells, suggesting that inefficient infection by srr mutants in BHK-R2 cells resulted from the absence of the effective receptor MHVR1. Virus-receptor binding tests failed to demonstrate a difference between the abilities of wt and srr18 to bind MHVR2. The binding of srr7 and srr11 to both MHVR1 and MHVR2 was revealed lower by two- to fourfold relative to the wt binding. The fusion activity of srr S proteins as examined by the expression with recombinant vaccinia virus was apparently lower than that of the wt S protein in BHK-R2 cells, while there was not such a remarkable difference in BHK-R1 cells. This suggests that the most likely reason for inefficient infection by mutants in BHK-R2 is impaired virus entry into cells. These observations suggest that inefficient infections in BHK-R2 cells by srr mutants occur in the absence of a functional receptor MHVR1, which plays an important role in srr entry into cells.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Taguchi, F" sort="Taguchi, F" uniqKey="Taguchi F" first="F" last="Taguchi">F. Taguchi</name>
</noCountry>
<country name="Japon">
<noRegion>
<name sortKey="Matsuyama, S" sort="Matsuyama, S" uniqKey="Matsuyama S" first="S" last="Matsuyama">S. Matsuyama</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006472 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006472 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:10891410
   |texte=   Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:10891410" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021